Atlas Trials

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

Clinical trial NCT01849250 · COMPLETED

Trial details

NCT number
NCT01849250
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Benign Breast NeoplasmDuctal Breast Carcinoma In SituInvasive Breast CarcinomaLobular Breast Carcinoma In SituPaget Disease of the BreastStage IA Breast CancerStage IB Breast CancerStage IIA Breast CancerStage IIB Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer
Start date
2013-05-01
Primary completion
2016-01-11
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.